Search Results - "Yu, A.P"

Health care resource utilization (HRU) and costs associated with disease activity in systemic lupus erythematosus (SLE): A retrospective observational cohort analysis by Kan, H, Guerin, A, Kaminsky, M, Yu, A.P, Wu, E.Q, Denio, A.E, Jhingran, P.M, Narayanan, S, Molta, C.T

Get full text

Comparing early intervention with zoledronic acid to no bisphosphonate (BP) therapy in patients with metastatic prostate cancer to bone: A study of the US Veterans Affairs (VA) population by Wu, E.Q, Guo, A, Shi, L, Lu, M, Yu, A.P, Sharma, H, Fan, C.P.S, Velde, N. Vander

Get full text

PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTS by Le, T.K, Winfree, K.B, Yang, H, Marynchenko, M, Yu, A.P, Frois, C, Wu, E.Q

Get full text

PSY32 - Health care resource utilization (HRU) and costs associated with disease activity in systemic lupus erythematosus (SLE): A retrospective observational cohort analysis by Kan, H., Guerin, A., Kaminsky, M., Yu, A.P., Wu, E.Q., Denio, A.E., Jhingran, P.M., Narayanan, S., Molta, C.T.

Get full text

Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension by Signorovitch, J., Zhang, J., Wu, E.Q., Latremouille-Viau, D., Yu, A.P., Dastani, H.B., Kahler, K.H.

“…Abstract Background: The approaching availability of lower-cost generic angiotensin receptor blockers (ARBs) may affect formulary policies for patients…”
Get full text

The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population by Velde, N V, Wu, E Q, Guo, A, Lu, M, Yu, A P, Sharma, H, Liu, J, Fan, C P S, Shi, L

“…To examine the effect of timely zoledronic acid (ZA) treatment on clinical outcomes and health care utilization in patients with bone-metastatic prostate…”
Get full text

P061 - Reduction in extraintestinal manifestations of Crohn's disease is associated with improvements in patient-reported and disease activity outcomes in patients treated with adalimumab by Reinisch, W., Lofberg, R., Louis, E., Yu, A.P., McHale, J., Beaulieu, N., Mulani, P., Chao, J.

Get full text

P246 - Young patients with Crohn's disease are at increased risk for psychiatric disorders by Loftus, E.V., Guérin, A., Yu, A.P., Wu, E., Chao, J., Mulani, P.

Get full text

Crystal structure and magnetic properties of YbZn0.7In1.3 by Yu. Verbovytskyy L.C.J. Pereira A.P. Gongalves

“…The new ternary YbZn0.7Inl.3 compound was synthesized in evacuated quartz ampoules at 900 ℃, followed by annealing at 400 ℃. It crystallized in the UHg2…”
Get full text